Overview
Scimitar syndrome, also known as pulmonary venolobar syndrome or congenital venolobar syndrome, is a rare congenital heart defect characterized by anomalous pulmonary venous return from the right lung to the inferior vena cava rather than to the left atrium. The name derives from the characteristic curvilinear shadow on chest X-ray that resembles a Turkish scimitar sword, created by the anomalous draining vein. The syndrome primarily affects the cardiovascular and pulmonary systems and is frequently associated with additional anomalies including right lung hypoplasia, dextroposition of the heart (shift of the heart to the right due to the small right lung), anomalous systemic arterial supply to the right lung from the aorta, and other congenital cardiac defects such as atrial septal defect. Scimitar syndrome presents in two main clinical forms. The infantile form typically manifests in the first year of life with symptoms of heart failure, pulmonary hypertension, tachypnea, recurrent respiratory infections, and failure to thrive, and tends to carry a more severe prognosis. The adult or childhood form is often milder and may be discovered incidentally on chest imaging, with patients remaining asymptomatic or experiencing only mild exertional dyspnea. Some patients develop recurrent right-sided pneumonias due to the associated pulmonary anomalies. Treatment depends on the severity of symptoms and the degree of left-to-right shunting. Asymptomatic patients with minimal shunting may require only monitoring. Surgical intervention is indicated for significant hemodynamic compromise and may include reimplantation of the anomalous vein into the left atrium, baffling of the anomalous venous drainage through an atrial septal defect, or in severe infantile cases, pneumonectomy of the hypoplastic right lung. Coil embolization of anomalous systemic arterial supply may also be performed. Outcomes are generally favorable for the childhood/adult form, while the infantile form carries higher morbidity and mortality, particularly when associated with pulmonary hypertension and additional cardiac malformations.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Scimitar syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Scimitar syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Scimitar syndrome.
Community
No community posts yet. Be the first to share your experience with Scimitar syndrome.
Start the conversation →Latest news about Scimitar syndrome
No recent news articles for Scimitar syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Scimitar syndrome
What is Scimitar syndrome?
Scimitar syndrome, also known as pulmonary venolobar syndrome or congenital venolobar syndrome, is a rare congenital heart defect characterized by anomalous pulmonary venous return from the right lung to the inferior vena cava rather than to the left atrium. The name derives from the characteristic curvilinear shadow on chest X-ray that resembles a Turkish scimitar sword, created by the anomalous draining vein. The syndrome primarily affects the cardiovascular and pulmonary systems and is frequently associated with additional anomalies including right lung hypoplasia, dextroposition of the hea
How is Scimitar syndrome inherited?
Scimitar syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Scimitar syndrome?
1 specialists and care centers treating Scimitar syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.